Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on: January 26,2024

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Updated on:January 26,2024

Liquid biopsy predicts immunotherapy response and toxicity in patients with advanced lung cancer

byJohns Hopkins University School of MedicineLiquid biopsy to study genetic material shed into bloodstream helps predict response to immunotherapy. Credit: Valsamo "Elsa" Anagnostou us

Updated on: January 25,2024

Liquid biopsy predicts immunotherapy response and toxicity in patients with advanced lung cancer

byJohns Hopkins University School of MedicineLiquid biopsy to study genetic material shed into bloodstream helps predict response to immunotherapy. Credit: Valsamo "Elsa" Anagnostou us

Updated on:January 25,2024

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei

Updated on: August 26,2024

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei

Updated on:August 26,2024

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on: January 05,2024

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on:January 05,2024

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m

Updated on: May 26,2024

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m

Updated on:May 26,2024

What are 'cancer vaccines,' and what similarities do they share with COVID vaccines?

by Sathana Dushyanthen,The ConversationCredit: AI-generated imageBarely a month goes by without headlines announcing yet another advancement in cancer vaccines.Just last month, the United States

Updated on: January 04,2024

What are 'cancer vaccines,' and what similarities do they share with COVID vaccines?

by Sathana Dushyanthen,The ConversationCredit: AI-generated imageBarely a month goes by without headlines announcing yet another advancement in cancer vaccines.Just last month, the United States

Updated on:January 04,2024

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on: January 10,2024

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on:January 10,2024

Diabetes medication class tied to lower risk of kidney stones

by Mass General BrighamCredit: Pixabay/CC0 Public DomainRates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidn

Updated on: May 26,2024

Diabetes medication class tied to lower risk of kidney stones

by Mass General BrighamCredit: Pixabay/CC0 Public DomainRates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidn

Updated on:May 26,2024

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Updated on: December 20,2023

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Updated on:December 20,2023

Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a

by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len

Updated on: December 26,2023

Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a

by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len

Updated on:December 26,2023

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Updated on: December 18,2023

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Updated on:December 18,2023